国际皮肤性病学杂志    2001 27 (4): 229-232   ISSN: 2096-5540  CN: 32-1880/R   抗核抗体和特异性自身抗体检测的临床应用 仇宁综述, 陈志强审校 中国医学科学院、中国协和医科大学皮肤病研究所 收稿日期 null  修回日期 null  网络版发布日期 null 参考文献  [1] Egner W.The use of laboratory tests in the diagnosis of SLE.J Clin Pathol,2000,53(6):424-432. [2] Mutasim DF,Adams BB.A practical guide for serologic evaluation of autoimmune connective tissue diseases.J Am Acad Dematol,2000,42(2Ptl):159-174. [3] Kavanaugh A,Tomar R,Reveille J,et al.Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens.Arch Pathol Lab Med,2000,124(1):71-81. [4] Dore N,Synkowski D,Provost TT.Antinuclear antibody determinations in Ro (SS-A)-positive,antinuclear antibody-negative lupus and Sjogron's syndrome patients.J Am Acad Dermgtol,1983,8(5):611-4615. [5] Suarez-Almazor ME,G,onzalez-Lopez L,Gamez-Nava JI,et al.Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.J Rheumatol,1998,25 (10):1980-1985. [6] Takeuchi Y,Ishikawa O,Miyachi Y.The comparative study of anti-dou-ble stranded DNA antibody levels measured by radioimmunoassay and en-zyme-linked immnosorbent assay in systemic lupus erythematosus.J Dermatol,1997,24(5):297-300. [7] Barada FA Jr,Andrews BS,Davis JS,et al.Antibodies to Sm in patients with SLE.Correlation of Sm antibody titers with disease activity and other laboratory parameters.Arthritis Rheum,1981,24(10):1236-1244. [8] Sprionk PE,Limburg PC,Kallenberg GM.Serologic markers of disease activity in SLE.Lupus,1995,4:86-94. [9] Thompson D,Juby A,Davis P.The clinical significance of autoantibody profiles in patients with SLE.Lupus,1993,2(1):15-19. [10] Sanchez-Guerrero J,Lew RA,Fossel AH,et al.Utility of anti-Sm,anti-RNP,anti-Ro/SS-A and anti-La/SS-B (extractable nuclear antigens) detected by enzyme linked immunosorbent assay for the diagnosis of SLE.Arthritis Rheum,1996,39(6):1055-1061. [11] Provost TT,Watson R,Simmons-O'Brien E.Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease.J Am Acad Dermatol,1996,35(2Pt1):147-169. [12] Yukiko N.Immunnoe responses to SS-A 52-kDa and 60-k Daproteins and to SS-B 50-kDa protein in mothers of infants with neonatal lupus erythematosus.Br J Dermatol,2000,142(5):908-912. [13] Jarzabek-Chorzelska M,Blaszczyk M,Jablonska S,et al.Scl-70 antibodies:a specific marker of systemic sclerosis.Br J Dermatol,1986,115 (4):393-401. [14] Reveille JD,Durban E,Goldstein R,et al.Racial differences in the frequencies of scleroderma-related autoantibodies.Arthritis Rheum,1992,35(2):216-218. [15] Combe B,Rucheton M,Graafiand H,et al.Clinical significance of anti-RNP and anti-Sm antoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue disease.Clin Exp Immunol,1989,75(1):18-24. [16] Yoshida S,Akizuki M,Mimori T,et al.The precipitating antibody to an acitic nuclear protein antigen,the Jo-1,in connective tissue disease.A marker for a subset of polymyositis with interstitial pulmonary fibrosis.Arthritis Rheum,1983,26(5):604-611. [17] Grossman L,Barland P.Histone reactivity of drug-induced antinuclear antibodies.A comparison of symptomatic and asymptomatic patients.Arthritis Rheum,1981,24(7):927-931. 通讯作者: